Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2010
10/21/2010US20100266539 Chemokine receptor antagonist and medical use thereof
10/21/2010US20100266509 Heteroaryl amide analogues as p2x7 antagonists
10/21/2010CA2758895A1 Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
10/21/2010CA2758245A1 Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/20/2010EP2240480A2 Derivatives of 2-heteroaroyl-imidazol(1,2-a)pyridine,preparation thereof and therapeutic application thereof
10/20/2010EP2240450A1 Trpa1 antagonists
10/20/2010EP2240434A1 2-phenyl phenoxyacetic acids useful for treating inflammatory disorders
10/20/2010EP2049491B1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
10/20/2010EP1921065B1 Phenylpyridone derivative
10/20/2010EP1899299B1 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
10/20/2010EP1381357B1 Glycyrrhetinic acid derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity
10/20/2010EP1317431B1 Polyarylcarboxamides useful as lipid lowering agents
10/20/2010EP1308438B1 3-substituted urea derivatives and medicinal use thereof
10/20/2010CN101863877A Therapeutic agents useful for treating pain
10/20/2010CN101863841A Substituted tetracycline compounds
10/20/2010CN101863830A Synthesis method of 2-amino-5-bromine isonicotinic acid
10/20/2010CN101863829A Synthesis method of 3-fluorine-4-aminopyridine
10/20/2010CN101863828A 3, 5, 6-three-halogenated pyridyl ethers compound and application thereof
10/20/2010CN101863827A N-ethyl-p-menthane-3-carboxamide derivative and preparation method thereof as well as application thereof as cooling agent
10/20/2010CN101863826A Method for preparing 2-benzyl pyridine compound
10/20/2010CN101863825A Ionic liquid containing carbamido group and pyridinium main ring and preparation method thereof
10/20/2010CN101863769A Synthesis method of 2-tetralone derivative
10/19/2010US7816557 Glucagon receptor antagonists, preparation and therapeutic uses
10/19/2010US7816535 such as N-[4-(1,4-dimethyl-1,2,5,6-tetrahydro-pyridin-3-yl)-phenyl]-2,6-difluoro-benzamide; immunosuppressive agents; allergic disorders, and immune disorders
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816523 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist; migraine; nerve system disorders
10/19/2010US7816408 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
10/19/2010US7816385 Dicarboxy compounds for use as drugs and receptors for proliferation
10/19/2010US7816382 Linear urea mimics antagonists of P2Y1 receptor useful in the treatment of thrombotic condition
10/19/2010US7816367 Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816352 Apoptosis inhibitors
10/19/2010US7816304 Mass labels
10/19/2010US7816016 hexacoordinated Indium complex made of ligand 1,1-bis(trifluoromethyl)-2-(diphenylphosphino)-ethanol and bis-cyclometallated Ir 2-(2,4-difluoro-3-perfluoroisopropyl-phenyl)-4-carbazolyl-pyridine
10/19/2010CA2433417C Novel 1,2-diphenylethene derivatives for treatment of immune diseases
10/19/2010CA2399840C Use of roflumilast or pumafentrine in combination with methotrexate for the treatment of arthritic diseases
10/14/2010WO2010116167A1 Ionic liquid solvents of perhalide type for metals and metal compounds
10/14/2010WO2010115688A1 Anthelmintic agents and their use
10/14/2010WO2010078906A3 Hydrazides method for production and use thereof as herbicide and insecticide
10/14/2010WO2009144395A8 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
10/14/2010WO2009144394A8 Polysubstituted 2-aryl-6-phenyl-imidazo[1,2-α]pyridine derivatives, and preparation and therapeutic use thereof
10/14/2010WO2009124013A8 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling
10/14/2010US20100261911 Therapeutic agent for trpv1-mediated disease
10/14/2010US20100261900 Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates
10/14/2010US20100261764 Substituted 3 -hydroxypyridines and pharmaceutical compositions thereof
10/14/2010US20100261763 Antibacterial agents and methods of use thereof
10/14/2010US20100261760 EP2 Receptor Agonists
10/14/2010US20100261758 Heterocyclic amides for use as pharmaceuticals
10/14/2010US20100261757 Insecticidal (Heteroarylalky)alkane Thio and Oxo Amine Derivatives
10/14/2010US20100261675 Fungicidal composition containing acid amide derivative
10/14/2010US20100261623 Corrosion inhibitor compositions comprising an aldehyde and a thiol and/or an amine functionalized ring structure and associated methods
10/14/2010US20100260750 Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity
10/14/2010DE102009016374A1 Preparing a 2-amino pyridine derivative comprises reacting an open-chain nitrile precursor with a nitrogen containing compound in a cyclization reaction
10/14/2010CA2758072A1 Macrocyclic serine protease inhibitors
10/14/2010CA2755669A1 Anthelmintic agents and their use
10/13/2010EP2238120A2 Improved process for making triphenylboron-pyridine compound
10/13/2010EP2238110A1 5.6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors
10/13/2010EP2238103A1 Novel n-(2-amino-phenyl)-amide derivatives
10/13/2010EP1204642B1 Fungicides
10/13/2010CN1886362B Preparation and use of alkylating agents
10/13/2010CN101861304A New thrombin function compounds and pharmaceutical compositions based on them
10/13/2010CN101861303A Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
10/13/2010CN101857567A Preparation method of high-purity 2,5-dipicolinic acid
10/13/2010CN101857566A Synthetic method of 2-hydroxypyridine compound
10/13/2010CN101857559A Chiral alpha-(trichloromethyl) amine compound and preparation method thereof
10/13/2010CN101857547A Preparation method of 2-nitro-1-aryl alcohol
10/13/2010CN101857517A Method for preparing fluorobiaryl compound in pure water solution
10/13/2010CN101856622A Pyridine base-synthesized cocrystallized zeolite catalyst and preparation method thereof
10/13/2010CN101121696B Metal salt of pyritinol and hydrate of the same
10/13/2010CN101108366B Method for manufacturing catalyst used for synthesizing 2-picoline
10/13/2010CN101084192B Manufacture of vitamin B6
10/12/2010US7812199 Hydroxyl compounds and compositions for cholesterol management and related uses
10/12/2010US7812171 Black pigment, black pigment dispersion and black resin composition comprising the same
10/12/2010US7812161 Synthesis of GlyT-1 inhibitors
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7812037 such as 4-{4-fluoromethyl-2-methyl-5-[(4-carbamimidoyl-benzyloxy)-methyl]-pyridin-3-yloxymethyl}-benzamidine, that inhibit the proteases of the blood and thus block platelet aggregation, used for the treatment of cardiovascular disorders
10/12/2010US7812025 neuroprotectants such as 4-biphenyl-3-yl-N-pyridin-3-ylpiperazine-1-carboxamide effective in prevention and treatment of cerebrovascular disorders such as necrosis, hemorrhages, injuries, as antidepressants and/or anxiolytic agents
10/12/2010US7811681 Electron transport compound and organic light emitting device comprising the same
10/12/2010US7811675 Luminance, high purity, low cost, and good thermal stability; as emitters for polymeric light-emitting diodes (PLEDs)
10/12/2010US7811595 Prolyl hydroxylase inhibitors and methods of use
10/12/2010CA2531543C Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
10/12/2010CA2478283C Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
10/12/2010CA2339761C Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
10/07/2010WO2010114723A1 Radiolabelling reagents and methods
10/07/2010WO2010114493A1 Lanthanide metal complexes useful in treating cancer
10/07/2010WO2010113957A1 Pharmaceutical composition for treating or preventing glaucoma
10/07/2010WO2010113955A1 Method for producing 2,6-diaminopyridine compound
10/07/2010WO2010113848A1 Isothiourea derivative or isourea derivative having bace1 inhibitory activity
10/07/2010WO2010113022A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010WO2010112177A1 Acylated aminopyridines and aminopyridazines as insecticides
10/07/2010WO2010043866A3 Histone lysine demethylase inhibitors
10/07/2010US20100256383 Compounds and Methods of Arylmethylation (Benzylation) As Protection For Alcohol Groups During Chemical Synthesis
10/07/2010US20100256202 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof
10/07/2010US20100256201 Cell differentiation inducer
10/07/2010US20100256200 Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
10/07/2010US20100256199 Crystalline form of an Antimalarial Compound
10/07/2010US20100256198 Method for decreasing symptoms of alcohol consumption
10/07/2010US20100256149 Novel arylamino n-heteraryl compounds as mek inhibitors
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010CA2757615A1 Plasminogen activator inhibitor-1 inhibitor